Clinical Determinants of Successful Omalizumab Therapy in Severe Allergic Asthma Patients: 4-Year-Long, Real-Life Observation.

Aleksandra KucharczykEwa Więsik-Szewczyk Anna Poznańska Karina Jahnz-Rozyk

Published in: Journal of asthma and allergy (2020)

Omalizumab therapy is very effective, with this efficacy sustained after 4 years of treatment. Success of the therapy can be predicted from the baseline FEV1% and clinical improvement (based on ACQ-7 and miniAQLQ scores) at week 16.

Keyphrases

ejection fraction
newly diagnosed
prognostic factors
chronic obstructive pulmonary disease
stem cells
clinical trial
mesenchymal stem cells
lung function
cell therapy
cystic fibrosis
air pollution
combination therapy